FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Aurora Daljit Singh 2. Issuer Name and Ticker or Trading Symbol Dermira, Inc. [ DERM ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Scientific Affairs Off
(Last)         (First)         (Middle)
C/O DERMIRA, INC., 275 MIDDLEFIELD ROAD, SUITE 150
3. Date of Earliest Transaction (MM/DD/YYYY)
11/11/2019
(Street)
MENLO PARK, CA 94025
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit   (1) 11/11/2019    A     6000.00       (2)  (1) Common Stock  6000.00  $0.00  6000.00  D   
Stock Options (Right to buy)  $8.05  11/11/2019    A     28000.00       (3) 11/10/2029  Common Stock  28000.00  $0.00  28000.00  D   

Explanation of Responses:
(1)  Each RSU represents a contingent right to receive one share of DERM common stock.
(2)  Vests as to 1/3rd of the shares on each of November 17, 2021, November 17, 2022, and November 17, 2023, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date.
(3)  The stock option vests and becomes exercisable as to 1/48th of the shares in equal monthly installments with the first 1/48th of the shares vesting on December 11, 2019, subject to the continuing employment of the Reporting person on the applicable vesting date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Aurora Daljit Singh
C/O DERMIRA, INC.
275 MIDDLEFIELD ROAD, SUITE 150
MENLO PARK, CA 94025


Chief Scientific Affairs Off

Signatures
/s/ Valerie Barnett as attorney-in-fact 11/13/2019
**Signature of Reporting Person Date
Dermira (NASDAQ:DERM)
Historical Stock Chart
From Aug 2020 to Sep 2020 Click Here for more Dermira Charts.
Dermira (NASDAQ:DERM)
Historical Stock Chart
From Sep 2019 to Sep 2020 Click Here for more Dermira Charts.